Zaleplon dosis bør reduceres hos patienter med mild til moderat leverinsufficiens, og zaleplon anbefales ikke til behandling af patienter med svær leverinsufficiens.
The dose of zaleplon should be reduced in patients with mild to moderate hepatic impairment, and zaleplon is not recommended for use in patients with severe hepatic impairment.